Switch to:
More From Other Websites
Novartis Licenses 2 Drugs In Exchange for Equity Mar 24 2017
Pharma Stock Roundup: Is Sanofi Buying Flexion? Pfizer, Merck KGaA Drug Approved Mar 24 2017
Novartis' Intraocular Lens Secures FDA Approval (NVS) Mar 23 2017
4:09 am Novartis' Alcon unit receives FDA approval for its AcrySof IQ ReSTOR +2.5 Multifocal Toric... Mar 23 2017
Novartis' Acute Heart Failure Drug Fails in Late-Stage Study Mar 22 2017
Novartis cancer drug combo developed partly in Cambridge shows early promise Mar 22 2017
Novartis Heart Drug Flops In Second Late-Stage Trial — As Expected Mar 22 2017
Novartis Shares Extend Declines After Serelaxin Fails Global Phase III Trials Mar 22 2017
Novartis’ Heart Drug Fails Late Stage Trials (NVS, AZN) Mar 22 2017
Does Novartis (NVS) Stock Make a Good Value Pick? Mar 21 2017
6 Reasons to Invest in GlaxoSmithKline (GSK) Stock in 2017 Mar 21 2017
Novartis’ Cosentyx Shows Psoriasis Modification Potential (NVS, DERM) Mar 21 2017
Our Ultimate Stock-Pickers' Top 10 Dividend-Yielding Stocks Mar 21 2017
Novartis (NVS) Announces Positive Data on Heart Failure Drug Mar 20 2017
Novartis Heart Failure Drug Beats Enalapril (NVS) Mar 20 2017
Flexi-Pricing Scheme Unveiled For Novartis AG (ADR) (NVS) Kisqali In The Face Of Stiff Competition Mar 16 2017
Novartis AG :NVS-US: Earnings Analysis: Q4, 2016 By the Numbers : March 16, 2017 Mar 16 2017
Novartis Introduces Flexible Pricing for Kisqali Mar 15 2017


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK